Given Imaging Esophageal PillCam Video Capsule Clearance Aids Stock Gain
This article was originally published in The Gray Sheet
Executive Summary
FDA clearance of Given Imaging's PillCam ESO 14-frame-per-second endoscopy video capsule for esophageal imaging Nov. 29 resulted in a 3.3% stock gain to $33.31 for the month
You may also be interested in...
Given Readies New Indications For PillCam And Prepares To Face Olympus
Given Imaging expects to launch its PillCam Colon endoscopic capsule in the U.S. in 2007, which will help the firm contend with its first competitor, Olympus
Given Readies New Indications For PillCam And Prepares To Face Olympus
Given Imaging expects to launch its PillCam Colon endoscopic capsule in the U.S. in 2007, which will help the firm contend with its first competitor, Olympus
Given PillCam ESO Reimbursed In Israel; U.S. Data Collection Underway
Given Imaging plans to take an incremental approach to garnering reimbursement for its PillCam ESO video capsule system, focusing initially on esophageal varices diagnosis coverage